×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)

MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)

货号:CL-0383

规格:1×10⁶cells/T25培养瓶

价格: ¥1600

生长培养基:Leibovitz's L-1510μg/ml Insulin+16μg/ml Glutathione+15% FBS1% P/S

数量: - +

  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
  • MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确) ¥1600

细胞培养最优解!

套餐组合价:¥2300¥2400

加入购物车

搭配套餐已成功加入购物车!

套餐2:

MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确) ¥1600

细胞培养最优解!

套餐组合价:¥2200¥2300

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
别称 MDA MB 436; MDA-Mb-436; MDA-MB436; MDAMB436; MDA-436; MDA436; MD Anderson-Metastatic Breast-436
种属 人类
生长特性 贴壁细胞
细胞形态 多角形
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
Leibovitz's L-1510μg/ml Insulin+16μg/ml Glutathione+15% FBS1% P/S
培养条件:
气相:空气,100%, 温度:37℃
培养方案B(可选)
生长培养基:
DMEM10μg/mL Insulin+16μg/mL Glutathione+15% FBS1% P/S
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:3
推荐换液频率 2-3次/周
注意事项 1.该细胞推荐使用Leibovitz's L-15培养基进行培养,Leibovitz's L-15不可以通入二氧化碳,会产生细胞毒性;2.如您没有无二氧化碳的培养箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培养基时即可正常通入5%二氧化碳;3.配套专用培养基默认Leibovitz's L-15配置,如需DMEM配方,请联系销售下单备注更改。
参考资料(来源文献)
背景描述 MDA-MB-436细胞源于一名43岁患有乳腺腺癌女性的胸腔积液;MDA-MB-436细胞呈多形性,大多数细胞在间接免疫荧光染色时呈现与抗微管抗体的强烈反应。
年龄(性别) 女性,43岁
组织来源 乳腺腺癌胸水转移灶
细胞类型 肿瘤细胞
肿瘤类型 乳腺癌细胞
生物安全等级 BSL-1
致瘤性 No, in immunosuppressed mice.Yes, in semisolid medium.
基因表达情况 tubulin; actin
保藏机构 ATCC; HTB-130
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 12
    D2S1338 23
    D3S1358 18
    D5S818 13
    D7S820 10
    D8S1179 10,14
    D13S317 10
    D16S539 9,11
    D18S51 12
    D19S433 13
    D21S11 30,31.2
    FGA 24
    PentaD 9
    PentaE 10,12
    TH01 9.3
    TPOX 8
    vWA 14,20
    D6S1043 11
    D12S391 20
    D2S441 10
  • STR鉴定图
参考文献
文献列表
  • The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation (2024-01-22)

    作者:Weijun Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Oncology Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. ; Wenjing Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Breast Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. ; Yingshi Zhou:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, G

    期刊:The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation

    DOI:10.1016/j.jbc.2024.105671

    影响因子 :4.8

    引用产品: MCF 10A 细胞 ,  HCC1806 细胞 ,  HCC1937 细胞 ,  MDA-MB-468 细胞 ,  BT-20 细胞 ,  Hs 578T 细胞 ,  MDA-MB-436 细胞 ,  MCF 10A细胞专用培养基 ,  HCC1806细胞专用培养基 ,  HCC1937细胞专用培养基 ,  MDA-MB-468细胞专用培养基 (L15) ,  BT-20细胞专用培养基 ,  Hs 578T细胞专用培养基 ,  MDA-MB-436细胞专用培养基 (L15)

  • Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer (2023-12-05)

    作者:Yan Yang:1.Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; 2.School of Laboratory Medicine, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; 3.School of Forensic Medicine, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; Jie Du:1.School of Laboratory Medicine, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; Yun-Fei Huang:1.School of Laboratory Medicine, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; Wei He:1.School of Laboratory Medicine, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; Li Liu:1.Clinical Medical College, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; Dan Li:1.Clinical Medical College, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ; Rui Chen:1.Department of General Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. ;

    期刊:Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer

    DOI:10.3892/ol.2023.14176

    影响因子 :2.9

    引用产品: MCF 10A 细胞 ,  T-47D 细胞 ,  SK-BR-3 [SKBR3] 细胞 ,  BT-549 细胞 ,  MDA-MB-468 细胞 ,  MDA-MB-436 细胞 ,  MDA-MB-231 细胞 ,  马血清 ,  MEM非必需氨基酸溶液 (NEAA),100×

  • LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells (2023-06-26)

    作者:Zhiwei Zhang:1.Department of Oncology, Affiliated Hospital of Hebei University of Engineering, Handan, 056000, Hebei, China. ; Yanli Yi:1.Department of Breast Surgery, Affiliated Hospital of Hebei University of Engineering, Handan, 056000, Hebei, China. ; Zai Wang:1.Science and Education Division, Affiliated Hospital of Hebei University of Engineering, Handan, 056000, Hebei, China. ; Haoyun Zhang:1.Department of Breast Surgery, Affiliated Hospital of Hebei University of Engineering, Handan, 056000, Hebei, China. ; Yanchun Zhao:1.Department of Breast Surgery, Affiliated Hospital of Hebei University of Engineering, Handan, 056000, Hebei, China. ; Ruijing He:1.Department of Breast Surgery, Affiliated Hospital of Hebei University of Engineering, Handan, 056000, Hebei, China. ; Yan Luo:1.Department of Reproductive Genetic, Hebei General Hospital, Shijiazhuang, 050000, Hebei, China. ; Zhiqiang Cui:1.Department of Breast Surgery, Affiliated Hospital of Hebei University of Engineering,

    期刊:LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells

    DOI:10.1007/s12033-023-00801-3

    影响因子 :2.6

    引用产品: MCF7 [MCF-7] 细胞 ,  MDA-MB-436 细胞 ,  293T [HEK-293T] 细胞 ,  RPMI-1640 培养基 ,  DMEM高糖 培养基

  • Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3 (2023-04-10)

    作者:Xue Hu:1.Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun City, Jilin Province, 130033, China. ; Baoliang Guo:1.Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin City, Heilongjiang Province, China. ; Tong Sun:1.Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun City, Jilin Province, 130033, China. ; Wan Wang:1.Department of Breast Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Avenue, Nanguan District, Changchun City, Jilin Province, 130033, China. ;

    期刊:Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3

    DOI:10.1515/med-2023-0635

    影响因子 :2.1

    引用产品: MCF 10A 细胞 ,  MCF7 [MCF-7] 细胞 ,  MDA-MB-231 细胞 ,  MDA-MB-436 细胞 ,  SK-BR-3 [SKBR3] 细胞 ,  DMEM/F12 培养基 ,  马血清 ,  MEM非必需氨基酸溶液 (NEAA),100× ,  青霉素-链霉素溶液 (双抗),100× ,  RPMI-1640 (ATCC改良) 培养基 ,  Leibovitz's L-15 培养基 ,  McCoy's 5A 培养基 ,  特级胎牛血清

  • FEZF2 inhibits the growth of triple-negative breast cancer cells through EZH2/PD-L1 and enhances anti-tumor immunity in vivo (2023-06-19)

    作者:Wenyu Li: 1.The Fifth Ward of the Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, No. 107 Huanhu East Road, Anhui, Hefei, China; Hu Liu: 1.The Fifth Ward of the Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, No. 107 Huanhu East Road, Anhui, Hefei, China; Wenjuan Li: 1.The Fifth Ward of the Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, No. 107 Huanhu East Road, Anhui, Hefei, China; Qiujun Zhang: 1.The Fifth Ward of the Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, No. 107 Huanhu East Road, Anhui, Hefei, China; Qianyu Zhang: 1.The Fifth Ward of the Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, No. 107 Huanhu East Road, Anhui, Hefei, China; Dandan Hu: 1.The Fifth Ward of the Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, No. 107 Huanhu East Road, Anhui, Hefei, China;

    期刊:FEZF2 inhibits the growth of triple-negative breast cancer cells through EZH2/PD-L1 and enhances anti-tumor immunity in vivo

    DOI:10.1007/s13273-023-00368-9

    影响因子 :1.7

    引用产品: MCF 10A 细胞 ,  DMEM/F12 培养基 ,  马血清 ,  青霉素-链霉素溶液 (双抗),100× ,  MDA-MB-231 细胞 ,  MDA-MB-468 细胞 ,  DMEM高糖 培养基 ,  BT-549 细胞 ,  RPMI-1640 培养基 ,  MDA-MB-436 细胞

  • DNAJB4 identified as a potential breast cancer marker: evidence from bioinformatics analysis and basic experiments (2012-00-20)

    作者:Linlong Mo:1.Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, China. ; Jiayou Liu:1.Human Anatomy Department of School of Basic Medical Sciences, North Sichuan Medical College, Nanchong, China. ; Ziquan Yang:1.Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, China. ; Xun Gong:1.Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, China. ; Fanlun Meng:1.Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, China. ; Rongyang Zou:1.Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, China. ; Lingmi Hou:1.Department of Breast and Thyroid Surgery, Hepatobiliary and pancreatic institution, Affiliated Hospital of North Sichuan Medical College, Nanchong, China. ; Fang Fang:1.Department of Thyroid and Breast Surgery, The Fir

    期刊:DNAJB4 identified as a potential breast cancer marker: evidence from bioinformatics analysis and basic experiments

    DOI:10.21037/gs-20-431

    影响因子 :1.8

    引用产品: MCF 10A 细胞 ,  MDA-MB-231 细胞 ,  MDA-MB-436 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号